Compare Cassava Sciences Inc (FLNA) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Cassava Sciences Inc trades at $0.83 (market cap $39.40M), while Vanguard Real Estate Index Fund ETF trades at $90.45 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 1797× Cassava Sciences Inc's market cap, and Vanguard Real Estate Index Fund ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Vanguard Real Estate Index Fund ETF for 112 Days on average.
| FLNA | VNQ | |
|---|---|---|
Market Cap | $39.40M | $70.80B |
Volume | 759,018 | 6,073,580 |
Sector | Health | — |
52-Week High | $4.64 | $100.95 |
52-Week Low | $0.68 | $87.00 |
Typical Hold Time | 37 Days | 112 Days |
Enterprise Value | -$43.28M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.84, up 2.72% today, with a bearish technical signal despite recent earnings beats. The company shows negative profitability metrics with ROE at -55.79% and ROA at -35.34%, though valuation ratios like EV/EBITDA of 1.03 and P/B of 0.62 suggest potential undervaluation. Recent FDA clearance for epilepsy drug trials provides a positive catalyst, but negative cash flow trends and zero revenue remain concerns.
The outlook hinges on clinical trial success and revenue generation. Analyst consensus is bullish with 67% buy ratings, but high execution risk and cash burn require careful monitoring. Near-term catalysts include Phase 2a trial initiation in 2027, while financial sustainability remains the primary challenge for investors.
VNQ trades at $90.02, up 1.5% today amid a bearish technical trend. The ETF faces pressure from rising Treasury yields, with moving averages signaling sell conditions. Recent news highlights institutional buying despite sector headwinds, as REITs grapple with interest rate sensitivity and valuation concerns. The dividend yield remains a focal point, though competition from T-bills challenges its income appeal.
Outlook: Near-term risks from Fed policy and sector rotation persist, but contrarian opportunities exist for long-term investors. Key risks include interest rate volatility and economic slowdowns, while potential upside hinges on rate stabilization and real estate demand recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
